Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure
February 04, 2025 07:30 ET
|
Quoin Pharmaceuticals, Inc.
Multi-pronged media campaign to raise awareness about the disease and its impact on patients, family members and caregivers.Interactive, stand-alone NETHERTON NOW website launched.Quoin’s QRX003...
Evento sobre alergias cutáneas (SAM) 2025 de la EAACI-ESCD: innovaciones pioneras en alergias cutáneas y dermatitis de contacto
February 04, 2025 03:00 ET
|
European Academy of Allergy and Clinical Immunology
ZÚRICH, Feb. 04, 2025 (GLOBE NEWSWIRE) -- El comité organizador se complace en anunciar la séptima edición del Evento sobre alergias cutáneas (SAM) de la EAACI-ESCD, el evento más importante de...
EAACI-ESCD Skin Allergy Meeting (SAM) 2025: Inovações pioneiras nas alergias da pele e na dermatite de contacto
February 04, 2025 03:00 ET
|
European Academy of Allergy and Clinical Immunology
ZURIQUE, Feb. 04, 2025 (GLOBE NEWSWIRE) -- A comissão organizadora tem o prazer de anunciar a sétima edição da EAACI-ESCD Skin Allergy Meeting (SAM), o principal evento da Europa dedicado às...
EAACI-ESCD Skin Allergy Meeting (SAM) 2025: Pioneering Innovations in Skin Allergy and Contact Dermatitis
February 04, 2025 03:00 ET
|
European Academy of Allergy and Clinical Immunology
ZURICH, Feb. 04, 2025 (GLOBE NEWSWIRE) -- The Organising Committee is delighted to announce the seventh edition of the EAACI-ESCD Skin Allergy Meeting (SAM), Europe’s leading event dedicated to skin...
Journey Medical Corporation to Host Conference Call to Discuss U.S. Commercial Launch Plan for Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
January 23, 2025 08:30 ET
|
Journey Medical Corporation
SCOTTSDALE, Ariz., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”), a commercial-stage pharmaceutical company that primarily focuses on selling and...
Plaque Psoriasis Market Research 2024-2034: Environmental and Genetic Factors Boost Demand, Investments in Medical R&D Catalyze Innovations
January 23, 2025 04:44 ET
|
Research and Markets
Dublin, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The "Plaque Psoriasis Market by Treatment, by Route of Administration, by End-user, and by Region" report has been added to ResearchAndMarkets.com's...
Allergy Treatment Market Size is Projected to Reach USD 64.65 billion by 2033, Growing at a CAGR of 6.46%: Straits Research
January 22, 2025 09:55 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Many of the population suffer from allergies, frequently associated with a low quality of life characterized by the constant fear of...
ViaDerma, Inc. Strengthens Global Expansion with New Dubai Office and Progress Towards Product Registration in India
January 21, 2025 08:00 ET
|
ViaDerma, Inc.
LOS ANGELES, Jan. 21, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and topical antibiotic products, is pleased to announce the opening of a...
Medical Lasers Market Size is Projected to Reach USD 12.02 billion by 2033, Growing at a CAGR of 9.10%: Straits Research
January 16, 2025 20:15 ET
|
Straits Research Private Limited - Garner Insights
New York, United States, Jan. 16, 2025 (GLOBE NEWSWIRE) -- Medical lasers are light-emitting devices used for treating or removing tissues. Non-ionizing radiation decreases blood loss, alleviates...
Cytrellis Biosystems launches Updated Next-Generation Skin Removal Treatment ellacor® 2.0, fueled by new leadership and financing
January 07, 2025 08:15 ET
|
Cytrellis Bioscience
Cytrellis marks new era of growth with the launch of ellacor 2.0, fueled by the completion of new financing and theappointment of Dr. Denise Dajles as CEO.